PDF) Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: A pooled analysis of the PRISMA I and II randomized trials
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events | NEJM